Murine models in mantle cell lymphoma

Best Practice and Research: Clinical Haematology

Volumn 25, Issue 2, 2012, Pages 153-163

  Zullo, Kelly ^a   Amengual, Jennifer E ^a   O'Connor, Owen A ^a   Scotto, Luigi ^a  

^a Department of Medicine   (United States)

Author keywords

cell bank; cell lines; mantle cell lymphoma; transgenic mouse models; xenograft mouse models

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CELL CYCLE REGULATION; CLINICAL EVALUATION; CYTOGENETICS; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; IMMUNOPHENOTYPING; IN VITRO STUDY; MANTLE CELL LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; TUMOR XENOGRAFT;

EID: 84862187133     PISSN: 15216926     EISSN: 15321924     Source Type: Journal    
DOI: 10.1016/j.beha.2012.04.009     Document Type: Review

References (39)

1. P. Perez-Galan, M. Dreyling, and A. Wiestner Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in genomic era Blood 117 2011 26 38
2. A. Agathangelids, A. Hadzidimitriou, and R. Rosenquist Unlocking the secrets of immunoglobin receptors in mantle cell lymphoma: implications for the origin and selection of malignant cells Semin Cancer Biol 21 2011 299 307
3. E. Flordal, M. Berglund, and R. Rosenquist Clonal development of a blastoid mantle cell lymphoma studied with comparative genomic hybridization Cancer Genet Cytogenet 139 2002 38 43 (Pubitemid 36120405)
4. F. Bertoni, E. Zucca, and F. Cotter Molecular basis of mantle cell lymphoma Br J Haematol 124 2004 130 140 (Pubitemid 38122184)
5. R. Rimokh, F. Berger, and G. Delsol Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas Blood 83 7 1994 1871 1875 (Pubitemid 24107911)
6. Fogli L, Williams M, Connors J, et al. Development and characterization of a mantle cell lymphoma cell bank in the American type culture collection. Submitted to Clinical Cancer Research, 2011.
7. C. Rudolph, D. Steinemann, and N. Von Neuhoff Molecular cytogenetic characterization of the mantle cell lymphoma cell line GRANTA-519 Cancer Genet Cytogenet 153 2 2004 144 150 (Pubitemid 39592147)
8. T. Katzenberger, C. Petzoldt, and S. Holler The Ki67 proliferation index is a quantitative indicator of clinical risk in mantle cell lymphoma Blood 105 8 2006 449 457
9. J. Camps, I. Salaverria, and M.J. Garcia Genomic imbalances and patterns of karyotypic variability in mantle-cell lymphoma cell lines Leuk Res 30 8 2006 923 993
10. L. Paoluzzi, L. Scotto, and E. Marchi Romidepsin and Belinostat synergize the antineoplastic effect of bortezomib in mantle cell lymphoma Clin Cancer Res 16 2010 554 565
11. M. Kelly-Sell, Y. Kim, and S. Straus The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T-cell lymphoma patients Am J Hematol 87 2012 354 360
12. Z. Qian, L. Zhang, and Z. Cai Lenalidomide synergizes with dexamethasone to induce growth arrest and apoptosis of mantle cell lymphoma cells in vitro and in vivo Leuk Res 35 2011 380 386
13. M. Wang, L. Zhang, and X. Han A severe combined immunodeficient-hu in vivo mouse model of human primary mantle cell lymphoma Clin Cancer Res 14 7 2008 2154 2160 (Pubitemid 351551128)
14. J. Bryant, L. Pham, and L. Yoshimura Development of intermediate-grade (mantle cell) and low-grade (small lymphocytic and marginal zone) human non-Hodgkin's lymphomas xenotransplanted in severe combined immunodeficieny mouse models Lab Invest 80 4 2000 557 573 (Pubitemid 30226637)
15. R. M'kacher, F. Farace, and A. Bennaceur-Griscelli Blastoid mantle cell lymphoma: evidence for nonrandom cytogenic abnormalities additional to t(11;14) and generation of a mouse model Cancer Genet Cytogenet 143 2003 32 38 (Pubitemid 36549005)
16. H. Lovex, A. Grzeschiczek, M. Bettine Kowalski, and T. Moroy Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice EMBO J 13 15 1994 3487 3495 (Pubitemid 24246185)
17. S. Bodruge, B. Warner, and M. Bath Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene EMBO J 13 9 1994 212 2130
18. A. Gladden, R. Woolery, and P. Aggarwal Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma Oncogene 25 2006 998 1007 (Pubitemid 43277008)
19. R. Ford, L. Shen, and Y. Chiu Lin-Lee Development of a murine model for blastoid variant mantle cell lymphoma Blood 109 11 2007 4899 4906 (Pubitemid 46827787)
20. Scotto L, Kruithof-de J, Paoluzzi L, et al. Development and characterization of a novel CD19-CherryLuciferase (CD19CL) transgenic mouse for the preclinical study of B-cell lymphomas. Submitted Clin Canc Res, Published online May 15, 2012.
21. R. Lai, T.J. McDonnell, and S.L. O'Connor Establishment and characterization of a new mantle cell lymphoma cell line, Mino Leuk Res 26 9 2002 849 855 (Pubitemid 34778500)
22. Z. Estrov, M. Talpaz, and S. Ku Z-138: a new mature B-cell acute lymphoblastic leukemia cell line from a patient with transformed chronic lymphocytic leukemia Leuk Res 22 4 1998 341 353 (Pubitemid 28271411)
23. J.V. Melo, V. Brito-Babapulle, and L. Foroni Two new cell lines from B-prolymphocytic leukaemia: characterization by morphology, immunological markers, karyotype and Ig gene rearrangement Int J Cancer 38 4 1986 531 538 (Pubitemid 16006925)
24. S.D. Raynaud, S. Bekri, and D. Leroux Expanded range of 11q13 breakpoints with differing patterns of cyclin D1 expression in B-cell malignancies Genes Chromosomes Cancer 8 2 1993 80 87 (Pubitemid 23293321)
25. D.L. Saltman, P.G. Cachia, and A.E. Dewar Characterization of a new non-Hodgkin's lymphoma cell line (NCEB-1) with a chromosomal (11:14) translocation [t(11:14)(q13;q32)] Blood 72 6 1988 2026 2030 (Pubitemid 19030893)
26. H.J. Jeon, C.W. Kim, and T. Yoshino Establishment and characterization of a mantle cell lymphoma cell line Br J Haematol 102 5 1998 1323 1326 (Pubitemid 28435219)
27. A. Zamo, G. Ott, and T. Katzenberger Establishment of the MAVER-1 cell line, a model for leukemic and aggressive mantle cell lymphoma Haematologica 91 1 2006 40 47 (Pubitemid 43235384)
28. M. Abe, Y. Nozawa, and H. Wakasa Characterization and comparison of two newly established Epstein-Barr virus-negative lymphoma B-cell lines. Surface markers, growth characteristics, cytogenetics, and transplantability Cancer 61 3 1988 483 490 (Pubitemid 18039362)
29. M. Daibata, M. Takasaki, and S. Hirose Establishment of a new human B cell line carrying t(11;14) chromosome abnormality Jpn J Cancer Res 78 11 1987 1182 1185 (Pubitemid 18012958)
30. H.G. Drexler, and R.A. MacLeod Malignant hematopoietic cell lines: in vitro models for the study of mantle cell lymphoma Leuk Res 26 9 2002 781 787 (Pubitemid 34784592)
31. M. Daibata, I. Kubonishi, and T. Eguchi The establishment of Epstein-Barr virus nuclear antigen-positive (SP-50B) and Epstein-Barr virus nuclear antigen-negative (SP-53) cell lines with t(11;14)(q13;q32) chromosome abnormality from an intermediate lymphocytic lymphoma Cancer 64 6 1989 1248 1253 (Pubitemid 19217102)
32. A. Goy, Y.K. Remache, and J. Gu Establishment and characterization of a new mantle cell lymphoma cell line M-1 Leuk Lymphoma 45 6 2004 1255 1260 37 (Pubitemid 38584911)
33. D. Rolland, V. Camara-clayette, and A. Barbarat Farnesytltransferase inhibitor R115777 inhibits cell growth and induces apoptosis in mantle cell lymphoma Cancer Chemother Pharmacol 61 5 2008 855 863 39 (Pubitemid 351305944)
34. L. Sun, L. Zhang, and J. Qian Combination of atriprimod and the proteasome inhibitor bortezomin induces apoptosis of mantle cell lymphoma in vitro and in vivo Leuk Res 36 3 2012 363 368 40
35. M. Gupta, A.E. Hendrickson, and S.S. Yun Dual mTORC1/mTORC2 inhibition diminishes Akt activation and induces Puma-dependent apoptosis in lymphoid malignancies Blood 119 2 2012 476 487
36. D. Mahadean, A. Stejskal, and L.S. Cooke Aurora A inhibitor (MLN8237) plus vincristine synergizes with rituximab as a potential curative therapy in aggressive B-cell non-Hodgkin lymphoma Clin Cancer Res 2012
37. R.J. Jones, V. Baladandayuthapani, and S. Neelapu HDM-2 inhibition suppresses expression fo ribonucleotide reductase subunit M2, and synergistically enhances gemcitabine induced cytotoxcity in mantle cell lymphoma Blood 118 15 2011 4140 4149
38. Q. Liu, L. Alinari, and C.S. Chen FTY720 shows promising in vitro and in vivo preclinical activity by downmodulating cyclin D1 and phospho-AKT in mantle cell lymphoma Clin Cancer Res 16 12 2010 3182 3192
39. C.A. Tucker, Al Kapanen, and G. Chikh Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1 nuclear factor-kappaB, p53, bax, p27 Mol Cancer Ther 7 4 2008 749 758 (Pubitemid 351551028)